Annual Accounts Payable
$301.60 K
+$167.50 K+124.91%
September 1, 2024
Summary
- As of March 10, 2025, DRUG annual accounts payable is $301.60 thousand, with the most recent change of +$167.50 thousand (+124.91%) on September 1, 2024.
- During the last 3 years, DRUG annual accounts payable has fallen by -$166.10 thousand (-35.51%).
- DRUG annual accounts payable is now -66.91% below its all-time high of $911.40 thousand, reached on September 30, 2022.
Performance
DRUG Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly Accounts Payable
$260.30 K
-$41.30 K-13.69%
December 1, 2024
Summary
- As of March 10, 2025, DRUG quarterly accounts payable is $260.30 thousand, with the most recent change of -$41.30 thousand (-13.69%) on December 1, 2024.
- Over the past year, DRUG quarterly accounts payable has dropped by -$342.40 thousand (-56.81%).
- DRUG quarterly accounts payable is now -71.44% below its all-time high of $911.40 thousand, reached on September 30, 2022.
Performance
DRUG Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Accounts Payable Formula
Accounts Payable = Beginning Accounts Payable + Purchases on Credit − Payments to Suppliers
DRUG Accounts Payable Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | +124.9% | -56.8% |
| 3 y3 years | -35.5% | -56.8% |
| 5 y5 years | +191.7% | -56.8% |
DRUG Accounts Payable Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3-year | -66.9% | +124.9% | -71.4% | +138.4% |
| 5 y | 5-year | -66.9% | +191.7% | -71.4% | +248.0% |
| alltime | all time | -66.9% | +191.7% | -71.4% | +248.0% |
Bright Minds Biosciences Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2024 | - | $260.30 K(-13.7%) |
| Sep 2024 | $301.60 K(+124.9%) | $301.60 K(+176.2%) |
| Jun 2024 | - | $109.20 K(-81.6%) |
| Mar 2024 | - | $592.80 K(-1.6%) |
| Dec 2023 | - | $602.70 K(+349.4%) |
| Sep 2023 | $134.10 K(-85.3%) | $134.10 K(-72.4%) |
| Jun 2023 | - | $485.50 K(+164.9%) |
| Mar 2023 | - | $183.30 K(-22.8%) |
| Dec 2022 | - | $237.40 K(-74.0%) |
| Sep 2022 | $911.40 K | $911.40 K(+204.8%) |
| Date | Annual | Quarterly |
|---|---|---|
| Jun 2022 | - | $299.00 K(-62.5%) |
| Mar 2022 | - | $796.80 K(+110.5%) |
| Dec 2021 | - | $378.50 K(-19.1%) |
| Sep 2021 | $467.70 K(+352.3%) | - |
| Sep 2021 | - | $467.70 K(+79.6%) |
| Jun 2021 | - | $260.40 K(-19.7%) |
| Mar 2021 | - | $324.20 K(+333.4%) |
| Dec 2020 | - | $74.80 K(-27.7%) |
| Sep 2020 | $103.40 K | - |
| Sep 2020 | - | $103.40 K |
FAQ
- What is Bright Minds Biosciences annual accounts payable?
- What is the all time high annual accounts payable for Bright Minds Biosciences?
- What is Bright Minds Biosciences annual accounts payable year-on-year change?
- What is Bright Minds Biosciences quarterly accounts payable?
- What is the all time high quarterly accounts payable for Bright Minds Biosciences?
- What is Bright Minds Biosciences quarterly accounts payable year-on-year change?
What is Bright Minds Biosciences annual accounts payable?
The current annual accounts payable of DRUG is $301.60 K
What is the all time high annual accounts payable for Bright Minds Biosciences?
Bright Minds Biosciences all-time high annual accounts payable is $911.40 K
What is Bright Minds Biosciences annual accounts payable year-on-year change?
Over the past year, DRUG annual accounts payable has changed by +$167.50 K (+124.91%)
What is Bright Minds Biosciences quarterly accounts payable?
The current quarterly accounts payable of DRUG is $260.30 K
What is the all time high quarterly accounts payable for Bright Minds Biosciences?
Bright Minds Biosciences all-time high quarterly accounts payable is $911.40 K
What is Bright Minds Biosciences quarterly accounts payable year-on-year change?
Over the past year, DRUG quarterly accounts payable has changed by -$342.40 K (-56.81%)